Pharma trade bodies have warned of negative impacts from tariffs, while analysts point to geopolitical catalysts.
TOKYO & PRINCETON, N.J.--(BUSINESS WIRE)--Otsuka Pharmaceutical Co., Ltd. (Otsuka) and its U.S. subsidiary, Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) announce termination of ...
Some disease areas bucked the trend of shrinking pipelines, however, with immune and cardiovascular indications seeing an ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
F rom blockbuster drugs that garner media attention to smaller innovations that help millions maintain health, the biotech and pharmaceutical industries have an impact on everyone’s life. Meanwhile, ...
The AACR Oncology Industry Partnering Event is an annual forum that brings together venture capitalists, investment bankers, biotech and pharmaceutical scientific and business leaders focused on ...
Dynamic Vapor Sorption (DVS) is a potent analytical technique used in the pharmaceutical industry to determine how much vapor a sample absorbs or desorbed under regulated temperature and humidity ...
A team of researchers has found a way to transform one of the world’s most dangerous chemicals into a valuable ingredient for medicines, offering new hope for both environmental cleanup and ...
InvestorsHub on MSN
Royalty Pharma signs $500M co-development agreement with J&J
Royalty Pharma plc (NASDAQ:RPRX) said it has entered into a research and development co-funding agreement with Johnson & ...
insights from industryShanoo BudhdeoDirector of Pharmaceutical ScienceSeda Pharmaceutical Development Services In this interview, NewsMedical speaks with Shanoo about her career progression and role ...
PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical, Co. Ltd. (Otsuka) today presented results from a pre-specified interim ...
The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results